Pharma Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Life science company reports record operating results
August 15th, 2005
Meridian Bioscience, Inc., (VIVO) reported record third quarter sales of $25,421,000, a 39% increase over the same period of the prior fiscal year and an all-time record for any quarter in the company's history. The company also reported record third quarter operating income of $5,708,000, an increase of 70% over the same period of the prior fiscal year and an all-time record for any quarter in the company's history. In addition Meridian reported record third quarter diluted earnings per share of $0.22, a 57% increase over the same period of the prior fiscal year based on 16,201,000 average diluted shares outstanding compared to 15,260,000 for the same period of fiscal...
Source: Pharma Business Week (2005-08-15)
|
